These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Creutzfeldt-Jakob disease following treatment with human pituitary hormones. Preece MA Clin Endocrinol (Oxf); 1991 Jun; 34(6):527-9. PubMed ID: 1889134 [No Abstract] [Full Text] [Related]
3. Virus scare halts hormone research. Norman C Science; 1985 Jun; 228(4704):1176-7. PubMed ID: 3890183 [No Abstract] [Full Text] [Related]
4. Iatrogenic Creutzfeldt-Jakob disease in Australia: time to amend infection control measures for pituitary hormone recipients? Solvyns SL; Ralston DW Med J Aust; 2011 Feb; 194(4):214-5; author reply 215. PubMed ID: 21401477 [No Abstract] [Full Text] [Related]
5. Creutzfeldt-Jakob disease. Adams AI Aust Fam Physician; 1991 Aug; 20(8):1216. PubMed ID: 1953464 [No Abstract] [Full Text] [Related]
6. [Creutzfeldt-Jakob disease in 4 children treated with growth hormone]. Billette de Villemeur T; Gourmelen M; Beauvais P; Rodriguez D; Vaudour G; Deslys JP; Dormont D; Richard P; Richardet JM Rev Neurol (Paris); 1992; 148(5):328-34. PubMed ID: 1448646 [TBL] [Abstract][Full Text] [Related]
7. Human growth hormone therapy and Creutzfeldt-Jakob disease: a drama in three acts. Brown P Pediatrics; 1988 Jan; 81(1):85-92. PubMed ID: 3275936 [No Abstract] [Full Text] [Related]
9. [A patient with Creutzfeldt-Jakob disease following treatment with human growth hormone]. Roos RA; Wintzen AR; Will RG; Ironside JW; van Duinen SG Ned Tijdschr Geneeskd; 1996 Jun; 140(22):1190-3. PubMed ID: 8692356 [TBL] [Abstract][Full Text] [Related]
10. The prismatic case of Creutzfeldt-Jakob disease associated with pituitary growth hormone treatment. Hintz RL J Clin Endocrinol Metab; 1995 Aug; 80(8):2298-301. PubMed ID: 7629222 [No Abstract] [Full Text] [Related]
11. Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States. Fradkin JE; Schonberger LB; Mills JL; Gunn WJ; Piper JM; Wysowski DK; Thomson R; Durako S; Brown P JAMA; 1991 Feb; 265(7):880-4. PubMed ID: 1992185 [TBL] [Abstract][Full Text] [Related]
12. Suspension of the Australian human pituitary hormone programme. Lazarus L Med J Aust; 1985 Jul; 143(2):57-9. PubMed ID: 3894895 [No Abstract] [Full Text] [Related]
13. [Creutzfeldt-Jakob disease and pituitary extracts]. Billette de Villemeur T Rev Prat; 1994 Oct; 44(15):2004-7. PubMed ID: 7984890 [No Abstract] [Full Text] [Related]
14. [Hypophyseal growth hormone and Creutzfeldt-Jakob disease in The Netherlands. Ad hoc Commission Creutzfeldt-Jakob-disease of the Dutch Growth Foundation]. Rikken B; Massa GG; Wit JM; van den Brande JL Ned Tijdschr Geneeskd; 1996 Jun; 140(22):1163-5. PubMed ID: 8692348 [No Abstract] [Full Text] [Related]
15. The missing link. Eaton L Nurs Times; 1993 Sep 22-28; 89(38):19. PubMed ID: 8415073 [No Abstract] [Full Text] [Related]
18. The clinical neurology and epidemiology of Creutzfeldt-Jakob disease, with special reference to iatrogenic cases. Brown P Ciba Found Symp; 1988; 135():3-23. PubMed ID: 3044708 [TBL] [Abstract][Full Text] [Related]
19. Creutzfeldt-Jakob disease with reference to the safety of pituitary growth hormone. Bannister BA; McCormick A J Infect; 1987 Jan; 14(1):7-12. PubMed ID: 3546511 [No Abstract] [Full Text] [Related]